{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:46:15Z","timestamp":1787021175024,"version":"build-2736575974"},"reference-count":15,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2008,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Osteonecrosis of the jaws (ONJ) was initially described in 2001 in patients receiving intravenous bisphosphonate (BP) treatment. The objective of the present study was to determine whether routine dental procedures can be considered as possible risk factors for the development of ONJ in breast cancer patients receiving BP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>Twenty breast cancer patients who developed ONJ receiving BP treatment were included in group A, whereas group B consisted of 40 matched controls (breast cancer patients who did not progress to ONJ receiving BP treatment). Routine dental care, smoking habits, history of tooth extraction, use of dentures, and root canal therapy were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results indicate that history of tooth extraction during zoledronic acid treatment (adjusted odds ratio [OR] = 16.4; 95% CI, 3.4 to 79.6) and the use of dentures (adjusted OR = 4.9; 95% CI, 1.2 to 20.1) increase the risk of developing ONJ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The outcome of the present study suggests early referral by oncologists for dental evaluation for every patient to be treated with BP. These results raise the current American Society of Clinical Oncology Level of Evidence linking certain dental procedures with ONJ from V to III. Further studies are needed to assess other possible risk factors and also to highlight the etiopathogenesis mechanism of ONJ.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.2008.16.2768","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T21:42:34Z","timestamp":1214257354000},"page":"4634-4638","source":"Crossref","is-referenced-by-count":185,"title":["Bisphosphonate-Related Osteonecrosis of the Jaws: A Case-Control Study of Risk Factors in Breast Cancer Patients"],"prefix":"10.1200","volume":"26","author":[{"given":"Athanassios","family":"Kyrgidis","sequence":"first","affiliation":[{"name":"From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Vahtsevanos","sequence":"additional","affiliation":[{"name":"From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Koloutsos","sequence":"additional","affiliation":[{"name":"From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Andreadis","sequence":"additional","affiliation":[{"name":"From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Boukovinas","sequence":"additional","affiliation":[{"name":"From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisis","family":"Teleioudis","sequence":"additional","affiliation":[{"name":"From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Patrikidou","sequence":"additional","affiliation":[{"name":"From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos","family":"Triaridis","sequence":"additional","affiliation":[{"name":"From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0931"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.2000.0210"},{"key":"R3","unstructured":"Garcia Saenz JA, Lopez TS, Garcia PB, et al: Osteonecrosis of the jaw as an adverse bisphosphonate event: Three cases of bone metastatic prostate cancer patients treated with zoledronic acid. Med Oral Patol Oral Cir Bucal 12:E351,2007\u2013E356,"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.017"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.9579"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200507073530120"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.8670"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06230.x"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2006.08.004"},{"key":"R10","unstructured":"Dimopoulos MA, Kastritis E, Anagnostopoulos A, et al: Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: Evidence of increased risk after treatment with zoledronic acid. Haematologica 91:968,2006-971,"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009876"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-3-199302010-00009"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1200\/jop.2006.2.1.7"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1075-122X.2006.00291.x"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Coleman RE: The role of bone markers in metastatic bone disease. Cancer Treat Rev 32:1,2006-2,  (suppl 1)","DOI":"10.1016\/S0305-7372(06)80001-0"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2008.16.2768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T16:21:38Z","timestamp":1653495698000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2008.16.2768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":15,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2008,10,1]]}},"alternative-id":["10.1200\/JCO.2008.16.2768"],"URL":"https:\/\/doi.org\/10.1200\/jco.2008.16.2768","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}